Skip to main content
. 2016 Nov 8;8(48):83446–83456. doi: 10.18632/oncotarget.13225

Figure 2. Precision and sensitivity of cfDNA-based NGS assay in detection of tumor tissue variants.

Figure 2

The precision (A) andsensitivity (B) were calculated for each gene listed in the middle using the formula at the bottom of the respective panel. TP indicates the number of true positives, or concordant variants; FP indicates false positives, or the number of variants in cfDNA but not present in tumor tissue; FN indicates false negatives, or the number of variants in tumor tissue but not in cfDNA.